Exploring psychological resilience and demoralisation in prostate cancer survivors

作者：Ching‐Hui Chien, See Tong Pang, Cheng‐Keng Chuang, Kuan‐Lin Liu, Chun Wu, Kai Yu, Xuan‐Yi Huang, Po‐Hung Lin · 发表于：European Journal of Cancer Care · 年份：2022 · DOI：10.1111/ecc.13759 · 被引用次数：22 · 研究领域：Cancer survivorship and care、Prostate Cancer Diagnosis and Treatment、Childhood Cancer Survivors' Quality of Life

OBJECTIVE: This study aimed to investigate psychological resilience and demoralisation and their predictors and mediators in prostate cancer survivors (PCSs). METHODS: A cross-sectional research design was used. PCSs (N = 122; mean time since diagnosis = 54.79 months, range in 13 years and 2 months) were recruited using convenience sampling at the outpatient department of a hospital in Taiwan. Data collection was conducted using self-report structured questionnaires, including one for demographic and disease characteristics, the Expanded Prostate Cancer Index Composite, Cancer Survivors' Self-Efficacy Scale, Connor-Davidson Resilience Scale and the Demoralisation Scale. RESULTS: In PCSs, a lower most-recent level of prostate-specific antigen and higher cancer-specific self-efficacy were associated with better psychological resilience. Further, fewer hormonal, bowel and urinary symptoms and bother; higher cancer-specific self-efficacy; and better psychological resilience were associated with less demoralisation. Cancer-specific self-efficacy was a mediator for the relationship between urinary symptoms and bother and demoralisation, while psychological resilience mediated the relationship between cancer-specific self-efficacy and demoralisation. CONCLUSIONS: The results reveal that cancer-specific self-efficacy is a protective factor against demoralisation and increases psychological resilience in PCSs. Better psychological resilience and fewer physical symptoms and bother are ...